New York Assembly Bill 265: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

New York · 2025-2026 session

What it does

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Latest action

REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS (2026-01-12)

See how A 265 affects you on CapitolKey

Browse more bills · CapitolKey home